Roivant Sciences

(NASDAQ) ROIV

Current Price$29.84

Market Cap$21.28B

Since IPO (2020)+184%

5 YearN/A

1 Year+175%

1 Month+6%

Roivant Sciences Financials at a Glance

Market Cap

$21.28B

Revenue (TTM)

$8.26M

Net Income (TTM)

-$299.77M

EPS (TTM)

-$0.50

P/E Ratio

-58.74

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$29.84

Volume

274,791

Open

$29.53

Price

$29.84

Volume

274,791

Open

$29.53

Previous Close

$29.58

Daily Range

$29.18 - $29.88

52-Week Range

$10.59 - $32.79

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$29.84

Volume

274,791

Open

$29.53

Previous Close

$29.58

Daily Range

$29.18 - $29.88

52-Week Range

$10.59 - $32.79

ROIV News

Page 1

ROIV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Roivant Sciences

Industry

Biotechnology

Sector

Health Care

Employees

721

CEO

Matthew Gline

Website

www.roivant.com

Headquarters

London, SW1Y 4LB, GB

ROIV Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

-156%

Net Income Margin

-36%

Return on Equity

-7%

Return on Capital

-24%

Return on Assets

-5%

Earnings Yield

-1.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.28B

Shares Outstanding

719.27M

Volume

274.79K

Avg. Volume

5.92M

Financials (TTM)

Gross Profit

$6.98M

Operating Income

-$1.29B

EBITDA

-$1.28B

Operating Cash Flow

-$750.35M

Capital Expenditure

-$8.21M

Free Cash Flow

-$758.56M

Cash & ST Invst.

$4.30B

Total Debt

$107.44M

Roivant Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$2.52M

-66.7%

Gross Profit

$2.20M

-70.1%

Gross Margin

87.30%

N/A

Market Cap

$21.28B

N/A

Market Cap/Employee

$23.43M

N/A

Employees

908

N/A

Net Income

$302.99M

+246.7%

EBITDA

-$354.36M

-25.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.19B

-12.5%

Accounts Receivable

$789.84M

N/A

Inventory

$0.00

N/A

Long Term Debt

$96.29M

+6.6%

Short Term Debt

$11.15M

+13.3%

Return on Assets

-5.23%

N/A

Return on Invested Capital

-23.60%

N/A

Free Cash Flow

-$165.08M

+4.8%

Operating Cash Flow

-$163.82M

+5.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EXASExact Sciences Corporation

EXASExact Sciences Corporation$104.91+0.00%

RPRXRoyalty Pharma plc

RPRXRoyalty Pharma plc$54.45+0.90%

MRNAModerna, Inc.

MRNAModerna, Inc.$46.79-1.72%

JAZZJazz Pharmaceuticals plc

JAZZJazz Pharmaceuticals plc$235.00-1.08%

ASNDAscendis Pharma A/S

ASNDAscendis Pharma A/S$236.44+0.50%

SMMTSummit Therapeutics Inc.

SMMTSummit Therapeutics Inc.$17.47+0.60%

BBIOBridgeBio Pharma, Inc.

BBIOBridgeBio Pharma, Inc.$68.15+2.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.15+0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.49-0.02%

ATPCAgape Atp

ATPCAgape Atp$6.35+1.23%

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF$28.24+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.45+0.01%

SIDUSidus Space

SIDUSidus Space$5.26-0.14%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.19+0.09%

Questions About ROIV

What is the current price of Roivant Sciences?

Roivant Sciences is trading at $29.84 per share.

What is the 52-week range for Roivant Sciences?

Over the past 52 weeks, Roivant Sciences has traded between $10.59 and $32.79.

How much debt does Roivant Sciences have?

As of the most recent reporting period, Roivant Sciences reported total debt of $107.44M.

How much cash does Roivant Sciences have on hand?

Roivant Sciences reported $1.42B in cash and cash equivalents in its most recent financial results.

What is Roivant Sciences’s dividend yield?

Roivant Sciences does not currently have a dividend yield.

Roivant Sciences

Roivant Sciences Financials at a Glance

ROIV News

Why Roivant Sciences Stock Is Soaring Today

Why Roivant Sciences Stock Bounced Back on Tuesday

Why Roivant Sciences Stock Was Slipping on Monday

Roivant Sciences Tops Q3 Expectations

Roivant Sciences Posts Mixed Q2

It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy

2 Magnificient Growth Stocks I'm Buying in August

Why Shares of Roivant Sciences Rose Wednesday

ROIV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Roivant Sciences

ROIV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Roivant Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ROIV

What is the current price of Roivant Sciences?

What is the 52-week range for Roivant Sciences?

How much debt does Roivant Sciences have?

How much cash does Roivant Sciences have on hand?

What is Roivant Sciences’s dividend yield?

Premium Investing Services